Month: January 2022

No Picture
News

BioTheryX Doses First Patient in Phase 1 Study Investigating Lead Protein Degrader Candidate BTX-1188

January 26, 2022 sandiegobiotech Comments Off on BioTheryX Doses First Patient in Phase 1 Study Investigating Lead Protein Degrader Candidate BTX-1188

SAN DIEGO: SAN DIEGO, Jan. 26, 2022 /PRNewswire/ — BioTheryX, Inc., a clinical-stage company focused on developing targeted protein degraders to create life-saving medicines, today announced dosing of the first patient in a new, first-in human Phase 1 study investigating its lead candidate BTX-1188, an oral, dual target protein degrader… Click here to view original post… […]

No Picture
Uncategorized

Senior Manager, Market Development – Biotech, North America – Thermo Fisher Scientific – San Diego, CA

January 26, 2022 sandiegobiotech Comments Off on Senior Manager, Market Development – Biotech, North America – Thermo Fisher Scientific – San Diego, CA

The Senior Manager, Market Development, Biotech for the Biosciences Division is a member of the North America Market Development team, responsible for the…From Thermo Fisher Scientific – Wed, 26 Jan 2022 08:26:20 GMT – View […]

No Picture
News

Zef Scientific and Evosep Partner to Increase and Improve US Service Coverage

January 25, 2022 sandiegobiotech Comments Off on Zef Scientific and Evosep Partner to Increase and Improve US Service Coverage

SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Today, Zef Scientific, Inc. and Evosep, announce that they have entered a partnership to increase and improve the US service coverage for the growing Evosep One install base. The agreement covers all service aspects from installations over warranty provision, preventive maintenance,… Click here to view original post… […]

No Picture
Uncategorized

Senior Research Associate / Research Associate, In Vivo Pharmacology – Fate Therapeutics – San Diego, CA

January 25, 2022 sandiegobiotech Comments Off on Senior Research Associate / Research Associate, In Vivo Pharmacology – Fate Therapeutics – San Diego, CA

B.S. degree in Cell Biology, Immunology or other related fields with a minimum of 2 years of in vivo laboratory experience in an academic, biotechnology,…From Fate Therapeutics – Tue, 25 Jan 2022 17:40:58 GMT – […]

No Picture
Uncategorized

Associate Scientist / Senior Research Associate, cGMP Cell Line Development (Cell Bank Testing) – Fate Therapeutics – San Diego, CA

January 25, 2022 sandiegobiotech Comments Off on Associate Scientist / Senior Research Associate, cGMP Cell Line Development (Cell Bank Testing) – Fate Therapeutics – San Diego, CA

M.S. or B.S. degree in a scientific discipline with minimum of 4 years of biotechnology, clinical, or pharmaceutical laboratory experience is required.From Fate Therapeutics – Tue, 25 Jan 2022 17:40:58 GMT – View all San […]

No Picture
Uncategorized

Senior Scientist / Scientist, Process Development (CAR-NK Biology) – Fate Therapeutics – San Diego, CA

January 25, 2022 sandiegobiotech Comments Off on Senior Scientist / Scientist, Process Development (CAR-NK Biology) – Fate Therapeutics – San Diego, CA

The successful candidate will be part of a multidisciplinary team to develop robust and consistent manufacture process for iPSC-derived NK (iNK) and T (iT) cell…From Fate Therapeutics – Tue, 25 Jan 2022 17:40:40 GMT – […]

No Picture
News

Capricor gets up to $735M for Duchenne drug’s US rights; PCI Biotech ends bile duct cancer clinical trial

January 25, 2022 sandiegobiotech Comments Off on Capricor gets up to $735M for Duchenne drug’s US rights; PCI Biotech ends bile duct cancer clinical trial

Capricor Therapeutics is still chugging along. The San Diego biotech signed a new collaboration with Japanese pharma company Nippon Shinyaku, whose US subsidiary is NS Pharma. Capricor earns a $30 million upfront payment to run its Phase III trial for its lead Duchenne cell therapy program while leaving the door… Click here to view original post… […]

No Picture
News

Active ingredient in cannabis protects aging brain cells

January 25, 2022 sandiegobiotech Comments Off on Active ingredient in cannabis protects aging brain cells

LA JOLLA—Decades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows how CBN can protect nerve cells from oxidative damage, a major pathway to… Click here to view original post… […]

No Picture
News

Section 32 Expands Investment Team with the Addition of Carlos Solórzano, Ph.D.

January 25, 2022 sandiegobiotech Comments Off on Section 32 Expands Investment Team with the Addition of Carlos Solórzano, Ph.D.

SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Section 32, a venture capital fund investing at the frontiers of technology and healthcare, announced today the addition of Carlos Solórzano, Ph.D., as Senior Principal to support the continued growth of its investing team. Carlos, an accomplished scientist, equity research analyst… Click here to view original post… […]

No Picture
News

Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial

January 25, 2022 sandiegobiotech Comments Off on Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Reports Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Trial Click here to view original post… […]

No Picture
News

Tony O’Neill Joins Ajinomoto Bio-Pharma Services’ Leadership Team as Vice President of Compliance

January 25, 2022 sandiegobiotech Comments Off on Tony O’Neill Joins Ajinomoto Bio-Pharma Services’ Leadership Team as Vice President of Compliance

SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O’Neill brings extensive experience leading Quality,… Click here to view original post… […]

No Picture
News

Senhwa’s Pidnarulex Receives US FDA Fast Track Designation for the Treatment of Solid Tumors with BRCA1/2, PALB2 and other HR Gene Mutations

January 25, 2022 sandiegobiotech Comments Off on Senhwa’s Pidnarulex Receives US FDA Fast Track Designation for the Treatment of Solid Tumors with BRCA1/2, PALB2 and other HR Gene Mutations

TAIPEI and SAN DIEGO: TAIPEI and SAN DIEGO, Jan. 25, 2022 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced today that the US Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for… Click here to view original post… […]

No Picture
Uncategorized

Principal Scientist/Associate Director, Chemistry – Crinetics Pharmaceuticals – San Diego, CA

January 24, 2022 sandiegobiotech Comments Off on Principal Scientist/Associate Director, Chemistry – Crinetics Pharmaceuticals – San Diego, CA

(Position will be filled at level commensurate with experience.). Lead/contribute to cross-functional teams in defining, aligning, and implementing strategies…From CRINETICS PHARMACEUTICALS – Tue, 25 Jan 2022 02:47:24 GMT – View all San Diego, CA jobsClick […]

No Picture
News

Roswell Biotechnologies Demonstrates First Scalable Molecular Electronics Chip in Peer-Review Paper

January 24, 2022 sandiegobiotech Comments Off on Roswell Biotechnologies Demonstrates First Scalable Molecular Electronics Chip in Peer-Review Paper

SAN DIEGO: SAN DIEGO, Jan. 24, 2022 /PRNewswire/ — The first molecular electronics chip has been developed, realizing a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law. Developed by Roswell Biotechnologies and a multi-disciplinary team of leading academic scientists, the chip… Click here to view original post… […]

No Picture
News

With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer’s Research

January 24, 2022 sandiegobiotech Comments Off on With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer’s Research

A joint gift to the University of Southern California (USC) and the University of California San Diego totaling $50 million from the Epstein Family Foundation will drive Alzheimer’s research and accelerate the search for treatments and a cure. Click here to view original post… […]